Par02 0003 01
Paremyd
Product Images NDC 17478-704
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Paremyd (NDC 17478-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Par02 0003 02
PAREMYD is an ophthalmic solution for eye-care that contains two active ingredients: Hydroxyamphetamine Hydrobromide USP at 1.0% and Tropicamide USP 0.25%. It also includes multiple inactive agents such as sodium chloride, Edetate Disodium, Preservative Benzalkonium Chloride 0.005%, and can contain either Hydrochloric Acid or Sodium Hydroxide to adjust the pH range between 4.2 t0 5.8. It is advised to refer to the package insert for dosage information, while storing the product at a temperature range of 20°C to 25°C (68°F to 77°F) and protecting it from light. PAREMYD is manufactured by Akorn, Inc, Lake Forest, IL 60045 in the USA, and the product is copyrighted in 2002.*
Par02 0003 03
This appears to be a prescription drug label for PAREMYD produced by Akorn, Inc. The drug contains active ingredients including Hydroxyamphetamine Hydrobromide, USP and Tropicamide, USP. PAREMYD is a medication used in eye examination procedures. The usual dosage should be found in the package insert, and the drug should be stored at 20°C to 25°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
